These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 16378788)

  • 1. Hepatitis B virus infection: current status.
    Ocama P; Opio CK; Lee WM
    Am J Med; 2005 Dec; 118(12):1413. PubMed ID: 16378788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus: from diagnosis to treatment.
    Dény P; Zoulim F
    Pathol Biol (Paris); 2010 Aug; 58(4):245-53. PubMed ID: 20580167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B vaccines: protective efficacy and therapeutic potential.
    Michel ML; Tiollais P
    Pathol Biol (Paris); 2010 Aug; 58(4):288-95. PubMed ID: 20382485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses in hepatitis B virus infection.
    Rehermann B
    Semin Liver Dis; 2003 Feb; 23(1):21-38. PubMed ID: 12616448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B: review of development from the discovery of the "Australia Antigen" to end of the twentieth Century.
    Yap SF
    Malays J Pathol; 2004 Jun; 26(1):1-12. PubMed ID: 16190102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
    Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
    Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B in children.
    Broderick AL; Jonas MM
    Semin Liver Dis; 2003 Feb; 23(1):59-68. PubMed ID: 12616451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and natural history of hepatitis B.
    McMahon BJ
    Semin Liver Dis; 2005; 25 Suppl 1():3-8. PubMed ID: 16103976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus core variants modify natural course of viral infection and hepatocellular carcinoma progression.
    Sung FY; Jung CM; Wu CF; Lin CL; Liu CJ; Liaw YF; Tsai KS; Yu MW
    Gastroenterology; 2009 Nov; 137(5):1687-97. PubMed ID: 19664630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward elimination and eradication of hepatitis B.
    Chen DS
    J Gastroenterol Hepatol; 2010 Jan; 25(1):19-25. PubMed ID: 20136972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virological analysis, genotypes and mutational patterns of the HBV precore/core gene in HBV/HCV-related hepatocellular carcinoma.
    De Mitri MS; Cassini R; Morsica G; Bagaglio S; Andreone P; Loggi E; Muratori P; Bernardi M
    J Viral Hepat; 2006 Sep; 13(9):574-81. PubMed ID: 16907843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy.
    Liaw YF
    Antivir Ther; 2006; 11(6):669-79. PubMed ID: 17310811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel approaches to new therapies for hepatitis B virus infection.
    Loomba R; Liang TJ
    Antivir Ther; 2006; 11(1):1-15. PubMed ID: 16518955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HBV and liver cancer.
    Leung N
    Med J Malaysia; 2005 Jul; 60 Suppl B():63-6. PubMed ID: 16108176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus infection.
    Chang MH
    Semin Fetal Neonatal Med; 2007 Jun; 12(3):160-7. PubMed ID: 17336170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of chronic hepatitis B virus infection: a new era of disease control.
    Farrell GC; Teoh NC
    Intern Med J; 2006 Feb; 36(2):100-13. PubMed ID: 16472264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B and liver transplantation.
    Tung BY; Kowdley KV
    Clin Infect Dis; 2005 Nov; 41(10):1461-6. PubMed ID: 16231258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prophylaxis, Diagnosis and Therapy of Hepatitis-B-Virus-(HBV-)Infection: upgrade of the guideline, AWMF-Register 021/011].
    Cornberg M; Protzer U; Dollinger MM; Petersen J; Wedemeyer H; Berg T; Jilg W; Erhardt A; Wirth S; Schirmacher P; Fleig WE; Manns MP
    Z Gastroenterol; 2007 Jun; 45(6):525-74. PubMed ID: 17554641
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of HBeAg-positive patients with nucleos/tide analogues.
    Coffin CS; Lee SS
    Liver Int; 2009 Jan; 29 Suppl 1():116-24. PubMed ID: 19207974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.